• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

NLRP3 变异与克罗恩病的遗传关联在一个大型英国面板中没有得到复制。

Genetic association between NLRP3 variants and Crohn's disease does not replicate in a large UK panel.

机构信息

IBD Genetics Research Unit, Department of Gastroenterology, Addenbrooke's Hospital, Hills Road, Cambridge, UK.

出版信息

Inflamm Bowel Dis. 2011 Jun;17(6):1387-91. doi: 10.1002/ibd.21499. Epub 2010 Oct 25.

DOI:10.1002/ibd.21499
PMID:21560198
Abstract

BACKGROUND

NLRP3 (formerly known as CIAS1 or NALP3) encodes a key component of the inflammasome and is a strong candidate gene for Crohn's disease (CD) susceptibility. A recent study reported significant and internally replicated association between CD and six single nucleotide polymorphisms (SNPs) in a regulatory region 5.3 kb downstream of NLRP3. Independent replication is required to verify these findings.

METHODS

In all, 1298 CD cases and 1244 healthy controls were genotyped for the six SNPs using Taqman. Single locus, haplotype, and subphenotype analyses were conducted using logistic regression-based methods and PLINK, respectively.

RESULTS

No significant associations were found, either on single locus, subphenotype, or haplotype analysis.

CONCLUSIONS

Given our high (>90%) power to replicate findings from the index study, our data suggest either a much smaller effect size for the association between NLRP3 and CD susceptibility than previously reported or the possibility of a false-positive result in the index study. Further studies in other populations are required to determine what role, if any, NLRP3 variants play in CD susceptibility.

摘要

背景

NLRP3(以前称为 CIAS1 或 NALP3)编码炎症小体的关键组成部分,是克罗恩病(CD)易感性的候选基因。最近的一项研究报告称,在 NLRP3 下游 5.3kb 的调控区域中,CD 与六个单核苷酸多态性(SNP)之间存在显著的、内部复制的关联。需要进行独立复制来验证这些发现。

方法

共对 1298 例 CD 病例和 1244 例健康对照进行了 NLRP3 下游 5.3kb 调控区域的六个 SNP 的 Taqman 基因分型。使用基于逻辑回归的方法和 PLINK 分别进行单基因座、单倍型和亚表型分析。

结果

无论是在单基因座、亚表型还是单倍型分析中,均未发现显著相关性。

结论

鉴于我们有很高(>90%)的能力复制索引研究中的发现,我们的数据表明,NLRP3 与 CD 易感性之间的关联效应大小比之前报道的要小得多,或者索引研究中存在假阳性结果的可能性。需要在其他人群中进行进一步的研究,以确定 NLRP3 变异体在 CD 易感性中起何种作用(如果有的话)。

相似文献

1
Genetic association between NLRP3 variants and Crohn's disease does not replicate in a large UK panel.NLRP3 变异与克罗恩病的遗传关联在一个大型英国面板中没有得到复制。
Inflamm Bowel Dis. 2011 Jun;17(6):1387-91. doi: 10.1002/ibd.21499. Epub 2010 Oct 25.
2
Common variants in the NLRP3 region contribute to Crohn's disease susceptibility.NLRP3区域的常见变异与克罗恩病易感性相关。
Nat Genet. 2009 Jan;41(1):71-6. doi: 10.1038/ng.285. Epub 2008 Dec 21.
3
Combined polymorphisms in genes encoding the inflammasome components NALP3 and CARD8 confer susceptibility to Crohn's disease in Swedish men.编码炎性小体成分NALP3和CARD8的基因中的联合多态性使瑞典男性易患克罗恩病。
Am J Gastroenterol. 2009 May;104(5):1180-8. doi: 10.1038/ajg.2009.29. Epub 2009 Mar 24.
4
Confirmation of the role of ATG16L1 as a Crohn's disease susceptibility gene.证实自噬相关基因16样蛋白1(ATG16L1)作为克罗恩病易感基因的作用。
Inflamm Bowel Dis. 2007 Aug;13(8):941-6. doi: 10.1002/ibd.20162.
5
Contribution of TNFSF15 gene variants to Crohn's disease susceptibility confirmed in UK population.TNFSF15基因变异对克罗恩病易感性的影响在英国人群中得到证实。
Inflamm Bowel Dis. 2008 Jun;14(6):733-7. doi: 10.1002/ibd.20399.
6
Two independent genetic factors responsible for the associations of the IBD5 locus with Crohn's disease in the Czech population.两个独立的遗传因素负责解释 IBD5 基因座与捷克人群克罗恩病的关联。
Inflamm Bowel Dis. 2011 Jul;17(7):1523-9. doi: 10.1002/ibd.21532. Epub 2010 Nov 8.
7
The missense variation Q705K in CIAS1/NALP3/NLRP3 gene and an NLRP1 haplotype are associated with celiac disease.CIAS1/NALP3/NLRP3 基因中的错义变异 Q705K 和 NLRP1 单倍型与乳糜泻有关。
Am J Gastroenterol. 2011 Mar;106(3):539-44. doi: 10.1038/ajg.2010.474. Epub 2011 Jan 18.
8
NLRP3 gene is associated with ulcerative colitis (UC), but not Crohn's disease (CD), in Chinese Han population.在中国汉族人群中,NLRP3基因与溃疡性结肠炎(UC)相关,但与克罗恩病(CD)无关。
Inflamm Res. 2014 Dec;63(12):979-85. doi: 10.1007/s00011-014-0774-9. Epub 2014 Oct 9.
9
Contribution of higher risk genes and European admixture to Crohn's disease in African Americans.高风险基因和欧洲混合对非裔美国人克罗恩病的贡献。
Inflamm Bowel Dis. 2012 Dec;18(12):2277-87. doi: 10.1002/ibd.22931. Epub 2012 Mar 12.
10
Associations of functional NLRP3 polymorphisms with susceptibility to food-induced anaphylaxis and aspirin-induced asthma.功能性NLRP3基因多态性与食物诱导的过敏反应及阿司匹林诱发哮喘易感性的关联
J Allergy Clin Immunol. 2009 Oct;124(4):779-85.e6. doi: 10.1016/j.jaci.2009.07.044. Epub 2009 Sep 19.

引用本文的文献

1
Research Progress on the Relationship between the NLRP3 Inflammasome and Immune Reconstitution in HIV-Infected Patients Receiving Antiretroviral Therapy.HIV 感染者抗反转录病毒治疗中 NLRP3 炎性小体与免疫重建的关系研究进展。
Comput Math Methods Med. 2022 Mar 10;2022:3179200. doi: 10.1155/2022/3179200. eCollection 2022.
2
Serum levels of NLRC4 and MCP-2/CCL8 in patients with active Crohn's disease.活性克罗恩病患者血清 NLRC4 和 MCP-2/CCL8 水平。
PLoS One. 2021 Nov 17;16(11):e0260034. doi: 10.1371/journal.pone.0260034. eCollection 2021.
3
Inflammasomes and Colorectal Cancer.
炎性体与结直肠癌。
Cells. 2021 Aug 24;10(9):2172. doi: 10.3390/cells10092172.
4
Inflammasome Regulation: Therapeutic Potential for Inflammatory Bowel Disease.炎症小体调控:炎症性肠病的治疗潜力。
Molecules. 2021 Mar 19;26(6):1725. doi: 10.3390/molecules26061725.
5
Role of pattern recognition receptors and the microbiota in neurological disorders.模式识别受体和微生物群在神经疾病中的作用。
J Physiol. 2021 Mar;599(5):1379-1389. doi: 10.1113/JP279771. Epub 2021 Jan 13.
6
Contradictory Effects of NLRP3 Inflammasome Regulatory Mechanisms in Colitis.NLRP3 炎症小体调控机制在结肠炎中的矛盾效应。
Int J Mol Sci. 2020 Oct 30;21(21):8145. doi: 10.3390/ijms21218145.
7
NLRP3 Inflammasome and Inflammatory Diseases.NLRP3 炎性小体与炎症性疾病
Oxid Med Cell Longev. 2020 Feb 17;2020:4063562. doi: 10.1155/2020/4063562. eCollection 2020.
8
Role of NLRP3 inflammasome in inflammatory bowel diseases.NLRP3 炎性小体在炎症性肠病中的作用。
World J Gastroenterol. 2019 Sep 7;25(33):4796-4804. doi: 10.3748/wjg.v25.i33.4796.
9
Targeting NLRP3 Inflammasome in Inflammatory Bowel Disease: Putting out the Fire of Inflammation.靶向 NLRP3 炎性小体治疗炎症性肠病:扑灭炎症之火。
Inflammation. 2019 Aug;42(4):1147-1159. doi: 10.1007/s10753-019-01008-y.
10
NLRP3 Inflammasome and Inflammatory Bowel Disease.NLRP3 炎性小体与炎症性肠病。
Front Immunol. 2019 Feb 28;10:276. doi: 10.3389/fimmu.2019.00276. eCollection 2019.